Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Duffull

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Clinical Pharmacology|August 23, 2000
The effect of body weight on dalteparin pharmacokinetics. A preliminary studyJ Y Yee, S B Duffull
Adverse Drug Reactions and Toxicological Reviews|January 1, 1994
Vancomycin toxicity. What is the evidence for dose dependency?S B Duffull, E J Begg
Clinical Toxicology (Philadelphia, Pa.)|August 23, 2013
Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported doseS B Duffull, G K Isbister
The New Zealand Medical Journal|August 8, 1998
Experience with heparin dosing at Christchurch HospitalM L Ward, S B Duffull
The Journal of Allergy and Clinical Immunology|April 1, 1992
Terfenadine ineffective in the prophylaxis of exercise-induced pruritusS B Duffull, E J Begg
Clinical Pharmacokinetics|July 28, 2001
Pharmacokinetic software for the health sciences: choosing the right package for teaching purposesB G Charles, S B Duffull
The New Zealand Medical Journal|August 11, 1993
The relevance of gluten in pharmaceutical productsS B Duffull, J R Gaudin
Australian and New Zealand Journal of Medicine|June 5, 1998
Another case of high gentamicin clearance and volume of distribution in a patient with high output ileostomyH A Ritchie, S B Duffull
Australian and New Zealand Journal of Medicine|April 1, 1997
Enhanced gentamicin clearance associated with ileostomy fluid lossT L Gaskin, S B Duffull
Clinical Pharmacology and Therapeutics|March 10, 2016
A framework for quantifying the influence of adherence and dose individualizationP Assawasuwannakit, R Braund, S B Duffull
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Clinical Pharmacology|August 23, 2000
The effect of body weight on dalteparin pharmacokinetics. A preliminary studyJ Y Yee, S B Duffull
Adverse Drug Reactions and Toxicological Reviews|January 1, 1994
Vancomycin toxicity. What is the evidence for dose dependency?S B Duffull, E J Begg
Clinical Toxicology (Philadelphia, Pa.)|August 23, 2013
Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported doseS B Duffull, G K Isbister
The New Zealand Medical Journal|August 8, 1998
Experience with heparin dosing at Christchurch HospitalM L Ward, S B Duffull
The Journal of Allergy and Clinical Immunology|April 1, 1992
Terfenadine ineffective in the prophylaxis of exercise-induced pruritusS B Duffull, E J Begg
Clinical Pharmacokinetics|July 28, 2001
Pharmacokinetic software for the health sciences: choosing the right package for teaching purposesB G Charles, S B Duffull
The New Zealand Medical Journal|August 11, 1993
The relevance of gluten in pharmaceutical productsS B Duffull, J R Gaudin
Australian and New Zealand Journal of Medicine|June 5, 1998
Another case of high gentamicin clearance and volume of distribution in a patient with high output ileostomyH A Ritchie, S B Duffull
Australian and New Zealand Journal of Medicine|April 1, 1997
Enhanced gentamicin clearance associated with ileostomy fluid lossT L Gaskin, S B Duffull
Clinical Pharmacology and Therapeutics|March 10, 2016
A framework for quantifying the influence of adherence and dose individualizationP Assawasuwannakit, R Braund, S B Duffull
Pageof 7